Runben Biotechnology Co., Ltd. (SHA:603193)
China
· Delayed Price · Currency is CNY 26.13
-0.03 (-0.11%)
Apr 29, 2026, 3:00 PM CST
Runben Biotechnology Revenue
Runben Biotechnology had revenue of 267.09M CNY in the quarter ending March 31, 2026, with 11.27% growth. This brings the company's revenue in the last twelve months to 1.57B, up 12.96% year-over-year. In the year 2025, Runben Biotechnology had annual revenue of 1.54B with 17.19% growth.
Revenue (ttm)
1.57B
Revenue Growth
+12.96%
P/S Ratio
6.73
Revenue / Employee
1.71M
Employees
921
Market Cap
10.57B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| C&S Paper Co.,Ltd | 8.78B |
| Guangdong Marubi Biotechnology | 3.46B |
| Shanghai Jahwa United | 6.32B |
| Chongqing Baiya Sanitary Products | 3.55B |
| Shanghai Flyco Electrical Appliance | 3.86B |
| Yunnan Botanee Bio-Technology Group Co.LTD | 5.53B |
| Hongmian Zhihui Science and Technology Innovation Co.,Ltd.Guangzhou | 2.11B |
| Mingchen Health | 1.51B |